ResMed | RMD - Ebitda


ResMed reported $547.48M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Ansell USD 185.8M 7M Dec/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 17.07M 2.79M Mar/2026
Baxter International USD -447M 873M Dec/2025
Cochlear AUD 306.4M 13.5M Dec/2025
Cooper Companies USD 323.4M 13.2M Dec/2025
CSL USD 3.13B 1.17B Dec/2025
Dexcom USD 364.5M 57.7M Mar/2026
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Fisher Paykel Healthcare NZD 364M 78.5M Jun/2025
Globus Medical USD 280.46M 27.86M Dec/2025
Haemonetics USD 94.78M 20.75M Dec/2025
Idexx Laboratories USD 400.87M 45.95M Mar/2026
Insulet USD 181.7M 12.3M Mar/2026
Integra LifeSciences USD 76.18M 28.03M Mar/2026
Intuitive Surgical USD 1.09B 165.5M Dec/2025
Masimo USD 85.5M 6.4M Mar/2026
Medtronic USD 2.81B 119M Mar/2026
Philips EUR 567M 233M Mar/2026
Ramsay Health Care AUD 1.12B 10.6M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Sigma Healthcare AUD 19.96M 5.15M Jul/2024
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Steris USD 394.7M 5M Dec/2025
Teleflex USD 247.07M 575.88M Dec/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026